Your browser doesn't support javascript.
loading
Neoadjuvant Anlotinib and chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced esophageal squamous cell carcinoma: Short-term results of an open-label, randomized, phase II trial.
Wang, Ying-Jian; Li, Kun-Kun; Xie, Xian-Feng; Bao, Tao; Hao, Zhi-Peng; Long, Jiang; Wang, Shuai; Zhong, Zhao-Yang; Guo, Wei.
Afiliación
  • Wang YJ; Department of Thoracic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Li KK; Department of Thoracic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Xie XF; Department of Thoracic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Bao T; Department of Thoracic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Hao ZP; Department of Thoracic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Long J; Department of Thoracic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Wang S; Department of Cancer Center, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Zhong ZY; Department of Cancer Center, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Guo W; Department of Thoracic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Front Oncol ; 12: 908841, 2022.
Article en En | MEDLINE | ID: mdl-35982957

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza